I-Ultram (tramadol) i- analgesic (i-painkiller) enqunyelwe ukulinganisa ubuhlungu obukhulu. I-opiate (i- narcotic ) kanye ne-monoamine-uptake inhibitor, okusho ukuthi yenza okungaphezulu kwamanye ama-neurotransmitter atholakale ebuchosheni bakho.
I-Ultram isetshenziselwa ukuphatha izinhlobo eziningi ze-neuralgia (ubuhlungu bezinzwa.) Ngezinye izikhathi zisetshenziselwa i- fibromyalgia , i- syndrome engenamaphiko , i- migraines , ne-obsessive-compulsive disorder.
I-Ultram ER (ukukhululwa okwedlule) kuyatholakala ekulawuleni ubuhlungu obunzima obungapheliyo amahora angu-24 ngosuku.
Indlela Esebenza ngayo
I-Ultram ibonakala isebenza ngezindlela ezimbalwa:
- Ithinta ama-receptors athile ochooid ebuchosheni (okusho ukuthi kushintsha indlela imiyalezo ebuhlungu egeleza ngayo amangqamuzana ebuchopho).
- Yandisa inani elitholakalayo le- serotonin ye-neurotransmitters ne-norepinephrine.
Lawo amakhemikhali angaba aphansi kubantu abane fibromyalgia. I-Serotonin ihilelekile ekucubunguleni ubuhlungu kanye nokujikeleza kokulala. I-Norepinephrine isiza umzimba wakho ukubhekana nokucindezeleka. Bobabili bakholelwa ukuthi badlala indima ezimpawu eziningi zalesi simo.
Sebenzisa ku-Fibromyalgia Pain Treatment
I-Ultram ayilona i-FDA evunyelwe ukuphatha ubuhlungu be-fibromyalgia , kodwa ngezinye izikhathi inqunywe ngaphandle kwelebula yaleso simo.
Sinezifundo ezimbalwa ezibonisa ukuthi zingasebenza, okufaka okungenani eyodwa ebonisa ukuthi yiyona kuphela i-painkiller ye-narcotic eboniswe ukusiza ngezinhlobo ezihlukahlukene ezibuhlungu ze-fibromyalgia.
Isifundo sezilwane esashicilelwe ngoJuni 2009 sibonisa ukuthi singase sisebenze ngokukhethekile ngokumelene ne- hyperalgesia (ubuhlungu obukhulu) we-fibromyalgia uma kuhlangene no- Savella (milnacipran) , kodwa le miphumela ayingakaze ichazwe kubantu.
Ucwaningo lwe-2015 olushicilelwe ku- Clinical Journal of Pain lwasikisela ukuthi i-tramadol yaholela ekuvakaseleni odokotela abambalwa kubantu abano-fibromyalgia.
Ukubuyekezwa kuka-2015 kwezidakamizwa ezidakamizwa kwaphetha ngokuthi kukhona ubufakazi obuhle obusekela ukusetshenziswa kwayo njengendlela yokwelashwa kwesibili kubantu abadinga ukuphumula okukhulu kunokwelashwa kwezidakamizwa ezigunyazwe yi-FDA.
Isilinganiso
Ukuze unciphise ingozi yemiphumela emibi, i-Ultram ivame ukuqala ngomthamo we-25 mg ngosuku futhi yanda kancane kancane ku-100-200 mg ngosuku.
Qinisekisa ukuthi ulandela iziqondiso zakho nodokotela kanye nokwenza umthamo wakho. Ngaphezu kuka-400 mg ngosuku kubhekwa njengengozi kubantu abaningi abadala. Ukunqunywa kokuphepha kulabo asebekhulile kunama-75 ngu-300 mg ngosuku.
Imiphumela emibi kanye nezixwayiso
Njengazo zonke izidakamizwa, Ultram ithatha ingozi yemiphumela emibi. Imiphumela emibi okufanele uyibike kudokotela wakho ngokushesha ihlanganisa:
- ukucindezeleka ukuphefumula noma wheyzing
- ukudideka
- itching
- ukuma noma ukuphelelwa amandla
- obomvu, ukugcoba, ukukhanda noma ukukhulula isikhumba
- ukuhlukunyezwa
Imiphumela emibi ngokuvamile ayidingi ukunakekelwa kwezempilo ngokushesha:
- ukuqotshwa
- isiyezi
- ukulala
- ikhanda
- isicasule noma ukuhlanza
Uma lemiphumela emibi iqhubeka noma iyinkinga kuwe, khuluma nodokotela wakho ngabo.
Uma unomlando wokulutha kwezidakamizwa noma utshwala, akufanele uthathe i-Ultram. Lesi sidakamizwa sibangele ukuqubuka kwamanye abantu futhi kungenza kube lula ukuthi uzothola ukuthunjwa uma unomlando wokugubha, ukulimala kwekhanda, isifo somzimba, noma ukuphuza imithi ethile (izidakamizwa zokucindezeleka, izidakamizwa zokuphumula, izidakamizwa ngenxa yokucabangela nokuhlanza.)
Ungadinga isilinganiso esikhethekile noma ukuhlolwa ukuze uthathe ngokuphepha u-Ultram uma unayo:
- isifo sezinso
- isifo sesibindi
- isifo somzimba
- umlando wokucindezeleka, ukugula kwengqondo noma ukuzama ukuzibulala
Futhi phawula: Uma uhlela ukumisa ukuthatha i-Ultram, kuzodingeka uyeke umthamo kancane ukuze ugweme izimpawu zokuhoxisa. Xoxa nodokotela wakho noma wezemithi mayelana nokuthi ungakuyeka kanjani ngokuphepha.
Izwi elivela
Uma ungathanda ukuzama ultram, khuluma nodokotela wakho. Kumele ube nesisindo sokunakekelwa okungcono nokuqapha ngaphambi kokuba wenze isinqumo. Uma uqala ukuthatha i-Ultram, qiniseka ukuthi ubukela imiphumela emibi futhi ukhulume nodokotela wakho nganoma yiziphi izinkinga onayo.
Imithombo:
Huynh CN, Yanni LM, Morgan LA. I-Journal ye-Health's Women's. 2008 Oct; 17 (8): 1379-87. I-Fibromyalgia: ukuxilongwa nokuphathwa komhlinzeki wezempilo oyinhloko.
Kaneko K, et al. Izincwadi ze-neuroscience. 2014 Mar 6; 562: 28-33. Umphumela we-tramadol we-analgesic ezinhlobonhlobo zezilwane zobuhlungu be-neuropathic ne-fibromyalgia.
Kim SH, et al. I-Korean Journal of Medicine yangaphakathi. 2009 Jun; 24 (2): 139-42. Umphumela wokusetshenziswa okuhlangene kwe-tramadol ne-milnacipran emzimbeni wobunzima emfanekisweni wezilwane we-fibromyalgia.
I-MacLean AJ, iStwartz TL. Ukubuyekezwa kochwepheshe we-neurotherapeutics. 2015 Meyi; 15 (5): 469-75. I-Tramadol yokwelashwa kwe-fibromyalgia.
I-Peng X, et al. Umagazini wezokwelapha wezinhlungu. 2015 Jan; 31 (1): 7-13. Ukuhlolwa kwesikhathi eside kwesikhumba se-opioid ku-fibromyalgia.